当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析

宏源药业

(301246)

  

流通市值:24.28亿  总市值:65.20亿
流通股本:1.49亿   总股本:4.00亿

宏源药业(301246)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.31亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益439251.03万元,未分配利润163217.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产564026.32万元,负债124775.29万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入426,063,8852,054,881,990.911,558,714,943.06997,633,605.73
营业总成本393,251,587.271,965,280,503.571,455,076,558.31928,911,489.22
营业利润35,165,805.81105,644,504.6122,096,871.1577,596,668.64
利润总额35,078,651.5898,558,063.56114,984,252.6576,092,913.33
净利润31,199,061.6287,168,626.2496,300,179.2265,023,439.88
其他综合收益----
综合收益总额31,199,061.6287,168,626.2496,300,179.2265,023,439.88
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,080,763,286.563,202,265,631.783,299,108,622.933,549,201,051.53
非流动资产合计2,559,499,940.452,448,505,159.562,261,135,584.132,160,590,689.47
资产总计5,640,263,227.015,650,770,791.345,560,244,207.065,709,791,741
流动负债合计875,870,777.75914,828,245.64786,138,440.73964,581,970.01
非流动负债合计371,882,129.89376,105,110.15404,337,538.92408,845,890.82
负债合计1,247,752,907.641,290,933,355.791,190,475,979.651,373,427,860.83
归属于母公司股东权益合计4,392,510,319.374,359,837,435.554,369,768,227.414,336,363,880.17
股东权益合计4,392,510,319.374,359,837,435.554,369,768,227.414,336,363,880.17
负债和股东权益合计5,640,263,227.015,650,770,791.345,560,244,207.065,709,791,741
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计162,314,968.391,440,669,124.49996,326,350.03532,521,074.14
经营活动现金流出小计251,812,636.321,405,418,725.75886,809,937.26642,804,987.18
经营活动产生的现金流量净额-89,497,667.9335,250,398.74109,516,412.77-110,283,913.04
投资活动现金流入小计1,346,719,951.553,220,414,364.731,927,064,684.89357,778.33
投资活动现金流出小计1,089,510,810.675,289,640,601.413,629,969,871.682,161,634,571.16
投资活动产生的现金流量净额257,209,140.88-2,069,226,236.68-1,702,905,186.79-2,161,276,792.83
筹资活动现金流入小计2,248,928.292,310,110,570.252,311,043,746.632,341,391,299.42
筹资活动现金流出小计5,682,843.93157,020,094.31132,261,431.84113,596,323.3
筹资活动产生的现金流量净额-3,433,915.642,153,090,475.942,178,782,314.792,227,794,976.12
汇率变动对现金及现金等价物的影响1,290,060.81570,348.75744,354.04324,789.17
现金及现金等价物净增加额165,567,618.12119,684,986.75586,137,894.81-43,440,940.58
期末现金及现金等价物余额521,972,103.32356,404,485.2822,857,393.26193,278,557.87
TOP↑